FDA Drug recall D-0249-2022
Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ…
- FDA Drug
- Class I
- terminated
- Published 2021-11-24
On 2021-11-24 the FDA classified a Class I recall of Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ… by Bayer Healthcare Pharmaceuticals, citing chemical Contamination: presence of benzene.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0249-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-10-01 |
| Published | 2021-11-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Bayer Healthcare Pharmaceuticals |
| Distribution | US |
Product
Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 58720 6, NDC 11523-0010-2.
Reason
Chemical Contamination: presence of benzene
Identifiers
| upc | 041100587206 |
|---|---|
| ndc | 11523-0010-1 |
| ndc | 11523-0010-2 |
| code_info | Lot # TN0023D, EXP 2/28/2022; TN004BX, EXP 6/30/2022; |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0249-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.